Skip to main content
Steven Lin, MD, Radiation Oncology, Houston, TX

StevenHseshengLinMDPhD

Radiation Oncology Houston, TX

Thoracic Cancer

Professor

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lin's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161
    Fax+1 713-563-2366

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 2004 - 2005
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 2006 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • American Board of Radiology Radiation Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveill...  
    Hong Yang, Steven H Lin, Annals of Surgical Oncology
  • Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆  
    Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect

Lectures

  • Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Nektar and Collaborators Present Late-Breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Nektar and Collaborators Present Late-Breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 7th, 2024
  • MD Anderson Research Highlights Special Edition: ESMO 2024
    MD Anderson Research Highlights Special Edition: ESMO 2024September 10th, 2024
  • Is FLASH the Future of Radiation Therapy?
    Is FLASH the Future of Radiation Therapy?September 30th, 2023
  • Join now to see all